ICD-10 Title: Sporotrichosis
ICD-10 B42 is a billable code used to indicate a diagnosis of icd-10 title: sporotrichosis.
Sporotrichosis is a fungal infection caused by the dimorphic fungus Sporothrix schenckii, which is commonly found in soil, plants, and decaying organic matter. The infection typically manifests as a subcutaneous infection characterized by nodular lesions that can ulcerate and drain. It is often associated with activities that involve handling plant material, such as gardening or farming. In immunocompetent individuals, sporotrichosis usually presents as a localized infection, but in immunocompromised patients, such as those with HIV/AIDS or undergoing chemotherapy, the disease can disseminate, leading to more severe systemic manifestations. Diagnosis is primarily clinical, supported by culture or histopathological examination. Treatment involves antifungal therapy, with itraconazole being the first-line agent. In severe cases, especially in immunocompromised patients, amphotericin B may be required. Early diagnosis and appropriate treatment are crucial to prevent complications, particularly in vulnerable populations.
Detailed patient history, including exposure risks and immune status.
Patients presenting with skin lesions after gardening or exposure to soil.
Documentation of culture results and response to antifungal therapy is critical.
Photographic evidence of lesions and detailed descriptions of clinical findings.
Patients with chronic skin lesions that do not respond to standard treatments.
Differentiating sporotrichosis from other dermatological conditions is essential.
Used to confirm the diagnosis of sporotrichosis.
Document the specimen source and culture results.
Infectious disease specialists may require additional lab results.
The primary treatment for sporotrichosis is itraconazole, which is effective for most cases. In severe or disseminated cases, amphotericin B may be necessary.
